Received Nov 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 1 | — | PO / MO |
States she took two doses of the oral typhoid vaccine (on Friday and Sunday), with two doses remaining. After the first dose, she developed a large, hard, tender knot (lymph node) that has since decreased in size, along with burning behind her eyes and throat tightness. Following the second dose, her lymph nodes enlarged from her ear down her neck, and her throat thickened/became tight again. Second dose reaction was stronger than first. Denies wheezing or difficulty breathing, chest pain, palpations. Denies fever, lymph node swelling. Symptoms have ultimately improved since yesterday w/ use of Benadryl; however, she is concerned about taking the remaining doses. Medical facility confirmed to be closed for holiday week. Health Dept called stated they have never seen a reaction to typhoid before, but they did tell us contact to inactivated version, which is carried at medical facility. Process for training appt received, given to patient. Advised that patient take remaining 2 doses of vaccine and high dose Benadryl 150 mg BID or TID if symptoms worsens. -Famotidine 20 mg BID for remainder of week. Once she makes appt with Health Dept, she will notify us of when that is going to be and we will send over medication (steroid, with Famotidine - Benadryl) for her to take in an effect of reaction preventative as she will began the inactivated version of the vaccine that day. Nursing to also report reaction to VAERS database.
N/A
Hypertension
HCTZ 12.5 mg one tab daily
Cefdinir, Cephalexin, and Cefadroxil